Compound Profile
Palmitoylethanolamide
Compound profile with evidence, safety, and practical fit.
Last reviewed:
B ModerateMonograph visual
Palmitoylethanolamide
Generated profile category visual
Where to go next — guides & comparisons
Continue reading
- If you want to browse more compounds → All compounds
Quick Stats
Evidence level
Moderate evidence
Typical onset
Varies by prep
Safety rating
Use extra caution: Generally well tolerated
Best for
PPAR Alpha, Mast Cells
Safety & Cautions
Review medications, pregnancy status, chronic conditions, and clinician guidance before use.
Evidence Summary
B ModerateEvidence lens
Useful signal, but study design, dose, and population still matter.
ModerateModerate evidence
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped — Inflammatory Signaling Modulation · Metabolic Regulation · Immune Signaling Modulation
Research maturity: More interpretable — main contexts: PPAR Alpha · Mast Cells
Safety boundary: Safety note available — Review medications, pregnancy status, chronic conditions, and clinician guidance before use.
Evidence Strength
Confidence estimate based on the design quality and consistency of published clinical trials.
Palmitoylethanolamide has a moderate evidence evidence rating.
General wellnessGeneral wellness
Effects
2
How evidence grades work
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
A
Strong
Multiple RCTs, consistent direction, adequate effect size
B
Moderate
Some RCTs or consistent observational data in humans
C
Preliminary / Mixed
Animal or in-vitro only, or conflicting human data
D
Traditional / Theoretical
Traditional use only; no controlled human trials
How Palmitoylethanolamide Works
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Palmitoylethanolamide Works
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & Biological Pathways▼
Preclinical mechanism details from scientific profiles; these represent plausible pathways but do not guarantee clinical efficacy in humans.
Inflammatory Signaling ModulationMetabolic RegulationImmune Signaling ModulationNeuroprotective ActivityLipid Metabolism Support
Condition guides
Continue exploring
Related research paths
Compare & Sourcing
Compare side-by-side tradeoffs or verify active marker guidelines.
Review available sources for Palmitoylethanolamide
Independent database mapping — evaluated separately from safety and efficacy scores.
Affiliate Disclosure: Shopping links may earn this site a commission at no cost to you. Links are chosen on quality and availability, never commission tiers; safety warnings and evidence ratings stay independent.
Related alternatives
Herbs for similar conditions
Tradeoffs
Free safety checklist
Get the Palmitoylethanolamide evidence notes
Occasional research updates, safety context, and product-quality checks for supplement decisions.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.
Affiliate-ready sourcing
PEA (Palmitoylethanolamide) product picks
Affiliate recommendations for Palmitoylethanolamide. Review safety, dose, and product quality before buying.
Affiliate disclosure: we may earn a commission from qualifying links at no extra cost to you. How we stay independent.
Product Form & Quality Guidelines
When sourcing Palmitoylethanolamide, verify the label for:
- Standardized Extract: Confirm active content percentages on the supplement facts panel (e.g. standardized to specific marker compounds) rather than simple raw herb weights.
- Third-Party Testing: Look for independent purity labels (USP, NSF, ConsumerLab, or Eurofins) to ensure the product is free from heavy metals, solvents, and contaminants.
- Form Bioavailability: Ensure the form matches evidence-supported configurations (e.g. chelated bisglycinate/glycinate for magnesium, micronized monohydrate for creatine) for optimal onset and digestion tolerance.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Editorial Review
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Compound profile context
How to interpret Palmitoylethanolamide
Palmitoylethanolamide dosage by use case, onset and duration, safety limits, and interactions for ppar alpha, graded against research. Moderate Human Evidence… Use this compound profile to understand mechanism, evidence quality, and practical safety context before comparing products or building a stack. A biochemical pathway connection can be useful for discovery, but it is not the same as proven benefit in humans.
When reviewing Palmitoylethanolamide, separate the active molecule from the product category around it. Dose form, absorption, extract standardization, medication interactions, and individual sensitivity can change the real-world risk-benefit picture.
For supplement planning, avoid combining multiple compounds with overlapping sedating, stimulating, serotonergic, blood-pressure, anticoagulant, or liver-metabolism effects unless a qualified clinician has reviewed the context.